CMD - Agilent price target lifted after guidance raise Travere downgraded on regulatory update; more in today's analyst action

Agilent price target raised by analysts after better than expected Q2 resultsSeveral firms have lifted the price target for Agilent Technologies (A) after the company raised the fiscal 2021 guidance and reported better-than-expected Q2 FY21 earnings. Agilent has added ~5.1% in the pre-market.Evercore ISI with an outperform rating has increased the price target by ~8.0% to $148.00 per share. The analyst points to strong organic growth “driven by broad based strength across end markets and geographies.”“The potential upside is not lost on us,” says the analyst from Stifel with a hold rating. The price target raised to $136.00 from $126.00 per share implies an upside of ~2.1%.Citing Agilent’s outperformance across all of its segments, “Execution deserves credit,” the analyst wrote, with a particular note on the high rate of growth of core pharma business and the signs of improvement at C&E.After the ~23% YoY growth in the quarter, Mike McMullen Agilent CEO said

For further details see:

Agilent price target lifted after guidance raise, Travere downgraded on regulatory update; more in today’s analyst action